SOPHiA GENETICS SA (SOPH) 股票分析

公司概述

SOPHiA GENETICS SA operates as a cloud-native software technology company within the healthcare sector, providing the SOPHiA DDM platform to analyze data and generate insights from multimodal data sets and diagnostic modalities. The company functions specifically within the Health Information Services industry, positioning itself to leverage advanced analytics for medical diagnostic modalities. As of the latest data, the company maintains a market capitalization of $348.31 million, with annual trailing twelve-month revenue reaching $77.27 million and an employee base of 415 individuals. These valuation and revenue figures indicate a mid-cap enterprise that has achieved significant revenue expansion while still operating with a relatively lean workforce compared to traditional hardware or large-scale pharmaceutical competitors. The current market cap suggests the market values the company at a premium relative to its current sales, reflecting high expectations for future software adoption and cloud scalability in the healthcare domain.

财务健康

The company reported trailing twelve-month revenue of $77.27 million against a net income loss of $-78,999,000 and an EBITDA of $-69,168,000, revealing a cost structure where operating expenses significantly exceed gross profits. Free cash flow stands at $-16,462,000, indicating that the company is currently burning cash to fuel its expansion rather than generating liquidity from operations. Gross margin is reported at 67.4%, which demonstrates high pricing power or efficient delivery of software services, yet this is offset by an operating margin of -85.4% and a profit margin of -102.2%. The operating margin indicates substantial overhead costs relative to revenue, while the negative profit margin reflects that net losses exceed the total revenue generated in the period. On the balance sheet, the company holds $70.29 million in cash against $63.02 million in debt, resulting in a debt-to-equity ratio of 133.67 which signifies a highly leveraged capital structure. Despite the high leverage, the current ratio of 1.96 suggests adequate short-term liquidity to cover current obligations without immediate distress. Return on equity is -110.0% and return on assets is -27.9%, metrics that reveal management is currently destroying value per unit of capital deployed due to the depth of the net loss position.

估值评估

The valuation metrics present a complex picture with a forward P/E of -8.68 and a trailing P/E marked as N/A due to the lack of positive earnings. The negative forward P/E implies that the market is pricing in significant future earnings improvement required to justify current stock prices, whereas the absence of a trailing P/E confirms the company is currently unprofitable on a historical basis. The price-to-book ratio stands at 7.06, indicating that the market values the company at more than seven times its book value, suggesting a high premium assigned to its intangible assets and growth potential. Alternative metrics such as a price-to-sales ratio of 4.51 and an EV/EBITDA of -4.93 further highlight that valuation is driven purely by top-line growth expectations rather than current profitability. The stock trades between a 52-week high of $5.70 and a 52-week low of $2.58, with the current price point relative to this range reflecting market volatility and sentiment shifts. The beta of 1.04 indicates that the stock's price volatility moves in tandem with the broader market, showing neither significant defensive characteristics nor excessive amplification of market swings.

Growth & Income

Revenue growth for the year-over-year period is 22.4%, while earnings growth is N/A due to the company's persistent losses. The divergence between strong revenue expansion and stagnant or negative earnings growth implies that revenue gains are being consumed by heavy investment in sales, general, and administrative expenses. As a non-dividend payer, the company has a dividend yield of N/A and a payout ratio of 0.0%, meaning all available cash is theoretically retained for reinvestment into growth initiatives rather than being distributed to shareholders. The sustainability of this strategy depends on the company's ability to convert its high gross margins into operating profit before the retention of earnings becomes viable. Overall, the growth and income profile is characterized by aggressive top-line expansion funded by significant cash burn and debt, with no current income distribution for shareholders.